PDF-ESMO Patient Guide Seriesbased on the ESMO Clinical Practice Guideline

Breast. Stomach cancer : - Information based on ESMO Clinical Practice Guidelines - v. 201 2 .1 Page 1 This document is provided by the Anticancer Fund with the permission of ESMO . The information in thi En dometrial Cancer - Information based on ESMO Clinical Practice Guidelines – v. 201 2 . 1 Page 1 This document is provided by the Anticancer Fund with the permission of ESMO . The inform Why is it different? . Why is it important?. Dr Avinash Gupta. Consultant in Medical Oncology. Melanoma Team – Christie NHS Foundation Trust. The Era of Immunotherapy. Cancer Type. Approved Immunotherapy. Best Practices & Overcoming Obstacles. Richard . Rosenfeld, SUNY Downstate. Peter Robertson and Stephanie Jones, AAO-HNS. The American Academy of Otolaryngology—Head and Neck Surgery (AAO-HNS) is the world's largest organization representing specialists who treat the ear, nose, throat, and related structures of the head and neck. . Lung and gastrointestinal cancers. Slide numbers. Study . Author. ESMO ID. 5 – 12. RATIONALE 304: . Tislelizumab + chemotherapy vs chemotherapy alone as 1L treatment for non-squamous NSCLC in patients who are smokers vs non-smokers. : a guide for patients – Information based on ESMO Clinical Practice Guidelines – v.201 4 .1 Page 1 This document is provided by the Anticancer Fund with the permission of ESMO . The information RecommendationLoE, GoRScreening with LDCT (low-dose computed topography)Reduces lung cancer-related mortality in high-risk subjects(heavy smokers [! 30 pack-years or " 15 years since cessation]aged 55 www.anticancerfund.orgwww.esmo.org $,!4,2!642!6$-#')-!6/$--+,!.+/*$%%$',!7/'*!89:;!4,&!-#+!3,-$(4,(+/!5),&!!!"DEF5E7!"G7E9"H $,!4,2!642!6$-#')-!6/$--+,!.+/*$%%$',!7/'*!89:;!4,&!-#+!3,-$(4,(+/!5),&!F,6 Prostate Cancer based on the ESMO Clinical Practice Guidelines What is Prostate Cancer ? Let us explain it to you. esmo.org En Cancer : a guide for patients - Information based on ESMO Clinical Practice Guidelines – v. 201 2 . 1 Page 1 This document is provided by the Anticancer Fund with the permission of ESMO . Th a guide for patients - Information based on ESMO Clinical Practice Guidelines – v.201 4 .1 Page 1 This document is provided by the Anticancer Fund with the permission of ESMO. The information in upper . gi. cancer HIGHLIGHTS . FROM ESMO 2022. Dr.. . Samuel J. . Klempner. , MD. Medical Oncologist, Massachusetts General Hospital, Boston, USA. Dr.. Yelena Y. . Janjigian. , MD. Medical Oncologist, Memorial Sloan Kettering Cancer . NSCLC, . gastric. . cancer. and . other. . solid . tumors.  .  . Contents: NSCLC. NSCLC,. . non-small cell lung cancer.. Slide numbers. Study . Abstract Number. Presenter. 4 - 10. RATIONALE-303: . RHG, Herning, Denmark. University of Southern Denmark, Odense, Denmark. implementation of ESMO guidelines in Clinical practice. Perspectives from a practicing oncologist. Disclosures. Personal fees: .